Isabel R Preeshagul

7PUBLICATIONS
53CO-AUTHORS
Satisfiability and optimisationMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 31, 2026
Patient Artificial Intelligence Literacy as a Component of Responsible Artificial Intelligence Implementation.

|Jun 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer.

Noura J Choudhury, W Victoria Lai, Alex Makhnin

|Oct 11, 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.

Humera Khurshid, Nofisat Ismaila, Jessica Bian

|Jun 29, 2023
Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer.

Rohit Thummalapalli, Ezra Bernstein, Benjamin Herzberg

|Feb 02, 2023
Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas.

Arielle Elkrief, Alex Makhnin, Khadeja A Moses

|Jul 12, 2021
Pilot Study of Dacomitinib for Patients With Metastatic EGFR-Mutant Lung Cancers With Disease Progression After Initial Treatment With Osimertinib.

Noura J Choudhury, Alex Makhnin, Yosef Y Tobi

Pageof 2

Frequent Collaborators

3 joint publications

Gregory J Riely

2 joint publications

Bob T Li

2 joint publications

Juliana Eng

2 joint publications

Marc Ladanyi